Groups. Trial II

First name:
Groups.
Middle name:
ASCLEPIOS I and ASCLEPIOS
Last name:
Trial
Suffix:
II
Hauser, S. ., Bar-Or, A. ., Cohen, J. ., Comi, G. ., Correale, J. ., Coyle, P. ., … Trial, G. A. I. and A. , II. (2020). Ofatumumab versus Teriflunomide in Multiple Sclerosis. The New England Journal of Medicine, 383(6), 546-557. https://doi.org/10.1056/NEJMoa1917246 (Original work published 2020)
View